{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:26:16Z","timestamp":1787293576377,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016003","name":"Istanbul University Cerrahpa\u015fa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      Hypophysitis is a heterogeneous clinical entity originating from different anatomical compartments of the pituitary gland and driven by diverse pathophysiological mechanisms. This study aims to explore the potential diagnostic and clinical value of\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose positron emission tomography in the evaluation of primary hypophysitis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      This single-center retrospective study was conducted at the pituitary referral unit of a tertiary university hospital. The study population included patients with primary hypophysitis, individuals with nonfunctioning pituitary adenomas, and subjects without intracranial pathology. Demographic features, baseline clinical and biochemical characteristics, as well as initial cranial and sellar magnetic resonance imaging and\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose positron emission tomography findings, were systematically analyzed and compared across groups. Furthermore, in the primary hypophysitis subgroup, potential associations between positron emission tomography imaging parameters and clinical, radiological, and laboratory characteristics were specifically examined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 46 participants were enrolled in the study, comprising 16 patients with primary hypophysitis, nine with nonfunctioning pituitary adenoma, and 21 controls without intracranial pathology. Positron emission tomography demonstrated significantly higher maximum and mean standardized uptake values in patients with primary hypophysitis compared with controls, whereas no significant differences were observed between the other groups. Within the primary hypophysitis cohort, mean standardized uptake values were significantly elevated in patients with hypopituitarism and in those with Arginine vasopressin deficiency (central diabetes insipidus) compared to their respective counterparts without these conditions. Furthermore, both maximum and mean standardized uptake values were markedly higher in patients with growth hormone deficiency than in those with preserved growth hormone function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These findings suggest that metabolic activity observed on\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose positron emission tomography may serve as a marker of disease severity and pituitary dysfunction in primary hypophysitis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-026-02907-2","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:06:43Z","timestamp":1779422803000},"page":"2267-2276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond MRI: Unveiling metabolic signatures of primary hypophysitis with 18F-FDG PET"],"prefix":"10.1007","volume":"49","author":[{"given":"Serdar","family":"Sahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul Banu","family":"Kocaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ufuk","family":"Yanmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said Erkam","family":"Biyikoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge Polat","family":"Korkmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sertac","family":"Asa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk Burcak","family":"Sayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande Mefkure","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necmettin","family":"Tanriover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-140X","authenticated-orcid":false,"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"6","key":"2907_CR1","doi-asserted-by":"publisher","first-page":"101371","DOI":"10.1016\/j.beem.2019.101371","volume":"33","author":"S Gubbi","year":"2019","unstructured":"Gubbi S, Hannah-Shmouni F, Verbalis JG, Koch CA (2019) Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation. Best Pract Res Clin Endocrinol Metab 33(6):101371. https:\/\/doi.org\/10.1016\/j.beem.2019.101371","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"2907_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/er.2004-0011","volume":"26","author":"P Caturegli","year":"2005","unstructured":"Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26(5):599\u2013614. https:\/\/doi.org\/10.1210\/er.2004-0011","journal-title":"Endocr Rev"},{"issue":"2","key":"2907_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/EJE-13-0642","volume":"170","author":"H Bando","year":"2014","unstructured":"Bando H, Iguchi G, Fukuoka H, Taniguchi M, Yamamoto M, Matsumoto R et al (2014) The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature. Eur J Endocrinol 170(2):161\u2013172. https:\/\/doi.org\/10.1530\/EJE-13-0642","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2907_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11102-015-0671-4","volume":"19","author":"A Faje","year":"2016","unstructured":"Faje A (2016) Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights. Pituitary 19(1):82\u201392. https:\/\/doi.org\/10.1007\/s11102-015-0671-4","journal-title":"Pituitary"},{"key":"2907_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejim.2019.08.008","volume":"68","author":"P Iglesias","year":"2019","unstructured":"Iglesias P, Cardona J, D\u00edez JJ (2019) The pituitary in nuclear medicine imaging. Eur J Intern Med 68:6\u201312. https:\/\/doi.org\/10.1016\/j.ejim.2019.08.008","journal-title":"Eur J Intern Med"},{"key":"2907_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.RLU.0000057554.55930.05","volume":"28","author":"RJ Campeau","year":"2003","unstructured":"Campeau RJ, David O, Dowling AM (2003) Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma. Clin Nucl Med 28:296\u2013298. https:\/\/doi.org\/10.1097\/01.RLU.0000057554.55930.05","journal-title":"Clin Nucl Med"},{"key":"2907_CR7","doi-asserted-by":"crossref","unstructured":"Hyun SH, Choi JY, Lee KH, Choe YS, Kim BT (2011) Incidental focal 18F FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria. J Nucl Med 52:547\u201350. https:\/\/doi.org\/110.2967\/jnumed.110.083733","DOI":"10.2967\/jnumed.110.083733"},{"key":"2907_CR8","doi-asserted-by":"publisher","first-page":"55544","DOI":"10.18632\/oncotarget.15417","volume":"8","author":"H Ju","year":"2017","unstructured":"Ju H, Zhou J, Pan Y, Lv J, Zhang Y (2017) Evaluation of pituitary uptake incidentally identified on 18F-FDG PET\/CT scan. Oncotarget 8:55544\u201355549. https:\/\/doi.org\/10.18632\/oncotarget.15417","journal-title":"Oncotarget"},{"key":"2907_CR9","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1097\/RLU.0b013e3182639765","volume":"38","author":"B Van der Hiel","year":"2013","unstructured":"Van der Hiel B, Blank CU, Haanen JB, Stokkel MP (2013) Detection of early onset of hypophysitis by 18F-FDG PET-CT in a patient with advanced stage melanoma treated with ipilimumab. Clin Nucl Med 38:e182\u2013e184. https:\/\/doi.org\/10.1097\/RLU.0b013e3182639765","journal-title":"Clin Nucl Med"},{"key":"2907_CR10","doi-asserted-by":"publisher","unstructured":"Habu M, Tokimura H, Hirano H, Yasuda S, Nagatomo Y, Iwai Y, Kawagishi J et al Pituitary metastases: current practice in Japan. J Neurosurg 123(04):998\u20131007. https:\/\/doi.org\/10.3171\/2014.12.JNS14870","DOI":"10.3171\/2014.12.JNS14870"},{"issue":"4","key":"2907_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1055\/s-0044-1787967","volume":"25","author":"A Stanly","year":"2024","unstructured":"Stanly A, Sunny SS, Benjamin J, Asha HS, Mathew D, John JR et al (2024) Utility of 18F-FDG PET\/CT in the Evaluation of Pituitary Uptake. World J Nucl Med 25(4):234\u2013241. https:\/\/doi.org\/10.1055\/s-0044-1787967","journal-title":"World J Nucl Med"},{"issue":"2","key":"2907_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11102-018-0875-5","volume":"21","author":"M Fleseriu","year":"2018","unstructured":"Fleseriu M, Karavitaki N (2018) Non-functioning pituitary adenomas, not all the same and certainly not boring! Pituitary 21(2):109\u2013110. https:\/\/doi.org\/10.1007\/s11102-018-0875-5","journal-title":"Pituitary"},{"issue":"4","key":"2907_CR13","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1210\/jc.2010-1048","volume":"96","author":"PU Freda","year":"2011","unstructured":"Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD et al (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(4):894\u2013904. https:\/\/doi.org\/10.1210\/jc.2010-1048","journal-title":"J Clin Endocrinol Metab"},{"key":"2907_CR14","doi-asserted-by":"publisher","unstructured":"Fleseriu M, Christ-Crain M, Langlois F, Gadelha M, Melmed S (2024) Hypopituitarism. Lancet. 15;403(10444):2632\u20132648. https:\/\/doi.org\/10.1016\/S0140-6736(24)00342-8","DOI":"10.1016\/S0140-6736(24)00342-8"},{"issue":"11","key":"2907_CR15","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R et al (2016) Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101(11):3888\u20133921. https:\/\/doi.org\/10.1210\/jc.2016-2118","journal-title":"J Clin Endocrinol Metab"},{"key":"2907_CR16","doi-asserted-by":"publisher","unstructured":"Fischer A, Mart\u00ednez-G\u00f3mez JM, Mangana J, Dummer R, Erlic Z, N\u00f6lting S et al (2024) 18F-FDG PET\/CT for Detection of Immunotherapy-Induced Hypophysitis-A Case-Control Study. Clin Nucl Med. 1;49(12):e656-e663. https:\/\/doi.org\/10.1097\/RLU.0000000000005440","DOI":"10.1097\/RLU.0000000000005440"},{"issue":"14","key":"2907_CR17","doi-asserted-by":"publisher","first-page":"1295865","DOI":"10.3389\/fendo.2023.1295865","volume":"29","author":"A Galligan","year":"2023","unstructured":"Galligan A, Iravani A, Lasocki A, Wallace R, Weppler AM, Sachithanandan N et al (2023) Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis. Front Endocrinol (Lausanne) 29(14):1295865. https:\/\/doi.org\/10.3389\/fendo.2023.1295865","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2907_CR18","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1210\/jc.2018-01021","volume":"103","author":"S Chiloiro","year":"2018","unstructured":"Chiloiro S, Tartaglione T, Capoluongo ED, Angelini F, Arena V, Giampietro A et al (2018) Hypophysitis outcome and factors predicting responsiveness to glucocorticoid therapy: a prospective and double-arm study. J Clin Endocrinol Metab 103:3877\u20133889. https:\/\/doi.org\/10.1210\/jc.2018-01021","journal-title":"J Clin Endocrinol Metab"},{"key":"2907_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-17-0123","volume":"177","author":"I Lupi","year":"2017","unstructured":"Lupi I, Cosottini M, Caturegli P, Manetti L, Urbani C, Cappellani D et al (2017) Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis. Eur J Endocrinol 177:127\u2013135. https:\/\/doi.org\/10.1530\/EJE-17-0123","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2907_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1055\/s-0044-101036","volume":"50","author":"A Angelousi","year":"2018","unstructured":"Angelousi A, Cohen C, Sosa S, Danilowicz K, Papanastasiou L, Tsoli M et al (2018) Clinical, Endocrine and Imaging Characteristics of Patients with Pri- mary Hypophysitis. Horm Metab Res 50(4):296\u2013302. https:\/\/doi.org\/10.1055\/s-0044-101036","journal-title":"Horm Metab Res"},{"issue":"1","key":"2907_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1055\/a-0919-4388","volume":"129","author":"OP Korkmaz","year":"2021","unstructured":"Korkmaz OP, Sahin S, Ozkaya HM, Apaydin T, Durmaz ES, Haliloglu O et al (2021) Primary hypophysitis: Experience of a Single Tertiary Center. Exp Clin Endocrinol Diabetes 129(1):14\u201321. https:\/\/doi.org\/10.1055\/a-0919-4388","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"9","key":"2907_CR22","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3174\/ajnr.A1714","volume":"30","author":"A Gutenberg","year":"2009","unstructured":"Gutenberg A, Larsen J, Lupi I, Rohde V, Caturegli P (2009) A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively. Am J Neuro- radiol AJNR Am J Neuroradiol 30(9):1766\u20137172. https:\/\/doi.org\/10.3174\/ajnr.A1714","journal-title":"Am J Neuro- radiol AJNR Am J Neuroradiol"},{"issue":"3","key":"2907_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11102-022-01213-3","volume":"25","author":"S Sahin","year":"2022","unstructured":"Sahin S, Yildiz G, Oguz SH, Civan O, Cicek E, Durcan E et al (2022) Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging\u2013derived texture features. Pituitary 25(3):474\u2013479. https:\/\/doi.org\/10.1007\/s11102-022-01213-3","journal-title":"Pituitary"},{"key":"2907_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1148\/radiology.177.1.2399336","volume":"177","author":"B De Souza","year":"1990","unstructured":"De Souza B, Brunetti A, Fulham MJ, Brooks RA, DeMichele D, Cook P et al (1990) Pituitary microadenomas: a PET study. Radiology 177:39\u201344. https:\/\/doi.org\/10.1148\/radiology.177.1.2399336","journal-title":"Radiology"},{"key":"2907_CR25","doi-asserted-by":"publisher","unstructured":"Francavilla L, Miletich RS, DeMichele D, Patronas NJ, Oldfield EH, Weintraub BD et al (1991) Positron emission tomography of pituitary macroadenomas: hormone pro- duction and effects of therapies. Neurosurgery 1991;28(826\u2013833). https:\/\/doi.org\/10.1097\/00006123-199106000-00007","DOI":"10.1097\/00006123-199106000-00007"},{"key":"2907_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3904\/kjim.2013.28.1.81","volume":"28","author":"H Seok","year":"2013","unstructured":"Seok H, Lee EY, Choe EY, Yang WI, Kim JY, Shin DY et al (2013) Analysis of 18F-fluor- odeoxyglucose positron emission tomography findings in patients with pituitary lesions. Korean J Intern Med 28:81\u201388. https:\/\/doi.org\/10.3904\/kjim.2013.28.1.81","journal-title":"Korean J Intern Med"},{"key":"2907_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2967\/jnumed.117.191916","volume":"59","author":"H Wang","year":"2018","unstructured":"Wang H, Hou B, Lu L, Feng M, Zang J, Yao S et al (2018) PET\/MRI in the diagnosis of hormone-producing pituitary microadenoma: a prospective pilot study. J Nucl Med 59:523\u2013528. https:\/\/doi.org\/10.2967\/jnumed.117.191916","journal-title":"J Nucl Med"},{"key":"2907_CR28","doi-asserted-by":"publisher","unstructured":"Hacioglu A, Karaca Z, Uysal S, Ozkaya HM, Kadioglu P, Soyluk Selcukbiricik O et al (2024) Evaluation and follow-up of patients diagnosed with hypophysitis: a cohort study. Eur J Endocrinol. 2024;191(3):312\u2013322. https:\/\/doi.org\/10.1093\/ejendo\/lvae101","DOI":"10.1093\/ejendo\/lvae101"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02907-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02907-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02907-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:08:48Z","timestamp":1787292528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02907-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2907"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02907-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}